The International Society for Neglected Tropical Diseases presented ISNTD d3 to address the past shortfalls in R&D productivity and drive the development of future paths towards successful gains in the control, treatment or evaluation of NTDs.
ISNTD d3 brought together experts from within drug discovery and clinical trials to drive the debate and foster new partnerships & alliances leading to tangible outcomes in terms of new therapies to combat these diseases.
ISNTD d3 aimed to accelerate the networking required for the development & distribution of new or improved drugs, vaccines, microbicides and diagnostics against the NTDs by bringing focus onto the phase II and III clinical trials taking place or set to take place potentially in affected countries.
Robert Don, DNDi Discovery & Pre-clinical Director, presented on drug discovery for leishmaniasis and Chagas disease.
New approaches and lessons learned in drug discovery for leishmaniasis and Chagas disease Robert Don, Discovery & Pre-clinical Director, DNDi
Leishmaniasis, Chagas disease & strategies for disease-specific treatments Chair: Simon Croft, London School of Hygiene and Tropical Medicine Robert Don, Discovery & Pre-clinical Director, DNDi |
More information: ISNTD d3 website
